Summit Therapeutics Income Statement (2016-2025) | SMMT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Apr2016	Jul2016	Oct2016	Jan2017	Apr2017	Jul2017	Oct2017	Dec2017	Jan2018	Apr2018	Jul2018	Oct2018	Jan2019	Mar2019	Jul2019	Oct2019	Dec2019	Mar2020	Dec2020	Dec2021	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Revenue & cost
Revenue	0.00B	0.00B	0.00B	0.00B	0.00B	0.03B	0.00B	2.81B	0.00B	0.01B	0.05B	0.00B	0.00B	0.00B	0.00B	0.00B		0.00B			0.00B						-0.00B	-0.00B
Operating items
Research & Development	-0.01B	-0.01B	-0.00B	-0.01B	-0.01B	-0.01B	-0.01B	-0.00B	-0.01B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B		-0.01B			0.02B	0.01B			0.02B	0.02B	0.03B	0.03B	0.04B	0.05B	0.05B	0.21B	0.13B
Share-based Compensation (IS)	0.01B
Selling, General & Administrative	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-757.04	-0.01B	-0.00B	-0.00B	-0.01B	-0.00B	-0.00B	-0.00B	-0.01B		-0.00B			0.01B	0.01B			0.01B	0.01B	0.01B	0.01B	0.02B	0.01B	0.02B	0.36B	0.10B
Other Operating Expenses					0.00B	0.00B		0.00B			-0.00B			0.00B			-0.00B				0.01B	0.00B			0.00B	0.00B		0.02B	-0.00B	0.00B
Operating Expenses	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.00B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.01B	-0.01B	-0.01B		-0.01B			0.02B	0.02B			0.02B	0.04B	0.04B	0.06B	0.06B	0.07B	0.07B	0.57B	0.23B
Operating Income	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	0.01B	-0.01B	426,331.73B	-0.02B	-0.01B	0.03B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B		-0.01B			-0.02B	-0.02B			-0.02B	-0.04B			-0.06B	-0.07B
EBIT	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	0.01B	-0.01B	426,331.73B	-0.02B	-0.01B	0.03B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B		-0.01B			-0.02B	-0.02B			-0.02B	-0.04B			-0.06B	-0.07B
Non-operating items
Interest & Investment Income	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	-0.00B	0.00B	-0.01B	0.00B	0.00B		0.00B		-0.00B
Other Non Operating Income	0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.00B		0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B				-0.00B
Non Operating Income																					-0.00B	0.01B			-0.00B	0.02B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Net income details
EBT	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	0.01B	-0.00B	0.00B	-0.02B	-0.01B	0.04B	-0.01B	-0.01B	0.01B	-0.01B	-0.01B		-0.01B			-0.02B	-0.02B			-0.02B	-0.04B			-0.06B	-0.07B
Tax Provisions	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-38.52	-0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B		0.00B
Profit After Tax	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	0.01B	-0.00B	286.88	-0.02B	-0.01B	0.03B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B		-0.01B			-0.02B	-0.02B			-0.02B	-0.04B	-0.04B	-0.06B	-0.06B	-0.06B	-0.06B	-0.57B	-0.23B
Income from Continuing Operations	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	0.01B	-0.01B	0.00B	-0.02B	-0.01B	0.04B	-0.01B	-0.01B	0.01B	-0.01B	-0.01B		-0.01B			-0.02B	-0.02B			-0.02B	-0.04B			-0.06B	-0.07B
Consolidated Net Income	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	0.01B	-0.01B	0.00B	-0.02B	-0.01B	0.04B	-0.01B	-0.01B	0.01B	-0.01B	-0.01B		-0.01B			-0.02B	-0.02B			-0.02B	-0.04B			-0.06B	-0.07B
Income towards Parent Company	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	0.01B	-0.01B	0.00B	-0.02B	-0.01B	0.04B	-0.01B	-0.01B	0.01B	-0.01B	-0.01B		-0.01B			-0.02B	-0.02B			-0.02B	-0.04B			-0.06B	-0.07B
Net Income towards Common Stockholders	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	0.01B	-0.01B	0.00B	-0.02B	-0.01B	0.04B	-0.01B	-0.01B	0.01B	-0.01B	-0.01B		-0.01B			-0.02B	-0.02B			-0.02B	-0.04B			-0.06B	-0.07B
Additional items
EPS (Basic)	13.00	13.00	9.00	-10.00	10.00		0.01		23.00	-11.21		13.00	-0.39	-3.91		-4.95		0.01			-0.10	-0.04			-0.03	-0.01	-0.06	-0.09	-0.08	-0.09	-0.09	-0.76	-0.31
EPS (Weighted Average and Diluted)													-0.50								-0.10	-0.04			-0.03	-0.01	-0.06	-0.09	-0.08	-0.09	-0.09	-0.76	-0.31
Shares Outstanding (Weighted Average)													0.02B				0.04B		0.07B	0.13B	0.21B	0.19B	0.38B	0.70B	0.70B	0.62B	0.70B	0.71B	0.73B	0.72B	0.74B	0.74B	0.74B
Shares Outstanding (Diluted Average)													0.02B				0.04B		0.07B	0.13B	0.21B	0.19B	0.38B	0.70B	0.70B	0.62B	0.70B	0.71B	0.73B	0.72B	0.74B	0.74B	0.74B
EBITDA	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	0.01B	-0.00B	731.80	-0.02B	0.01B	0.03B	-0.01B	-0.01B	0.01B	-0.01B	-0.01B		0.01B			-0.02B	-0.02B			-0.02B	-0.04B	-0.04B	-0.06B	-0.06B	-0.06B	-0.06B	-0.57B	-0.23B
Interest Expenses	-0.00B	-565.24	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-111.56	-0.00B	0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B		0.00B									0.00B	0.00B	0.00B	0.00B
Tax Rate	-15.15%	-14.76%	-16.60%	-21.89%	-20.17%	13.31%	-45.42%	-0.01%	1.74%	-14.22%	-1.81%	-13.56%	-12.93%	13.47%	-17.07%	-9.37%		-17.94%

Research Tools

Summit Therapeutics Income Statement (2016-2025) | SMMT

Create an account

Sign In

Reset Password